ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag nuclear chemistry disease medicine

A close up of several modular puzzle pieces.
Making Connections: Click Chemistry and Bioorthogonal Chemistry
Deanna MacNeil, PhD | Feb 13, 2024 | 5 min read
Simple, quick, and modular reactions allow researchers to create useful molecular structures from a wide range of substrates.
The Chemistry of Attraction
Michelle Vettese-dadey | Mar 5, 2000 | 6 min read
Chemokines and their receptors help direct cell migration to sites of inflammation. You heard it here--chemokine receptors and ligands are in. Inflammation, cancer, asthma, rheumatoid arthritis, angiogenesis, and AIDS are just a few areas in which chemokines and their receptors are crucial. Therefore, chemokine pathways represent potentially valuable therapeutic targets. Asthma, one of the most common chronic diseases in the industrialized world, is recognized as an inflammatory disease, and ste
Prions' Changeability: Nuclear magnetic resonance shows more pieces of the puzzle
Ricki Lewis | May 9, 1999 | 7 min read
Prions have been a tough sell. Against a backdrop of the "DNA to RNA to protein" credo, the idea that the same amino acid sequence could exist in multiple forms, both normal and deranged, seemed like heresy. But since Stanley Prusiner, a professor of neurology, virology, and biochemistry at the University of California, San Francisco (UCSF), named the agent that causes the transmissible spongiform encephalopathies (TSEs) "proteinaceous infectious particles" in 1982,1 evidence has been steadily
People: Columbia Professor To Receive ACS Organic Chemistry Award
The Scientist Staff | Feb 4, 1990 | 3 min read
Koji Nakanishi, Centennial Professor of Chemistry at Columbia University, has been selected to receive the American Chemical Society's 1990 Arthur C. Cope Award for outstanding achievement in organic chemistry. Nakanishi, 64, will be presented with a gold medal and $15,000 at the ACS national meeting, to be held in August in Washington, D.C. The award will also provide Columbia with a $30,000 research grant. Nakanishi, who has been at Columbia for 21 years, has gained international recognition
Protein Folding: Theory Meets Disease
Philip Hunter | Sep 7, 2003 | 10+ min read
Protein folding raises some of biology's greatest theoretical challenges. It also lies at the root of many diseases. For example, the fundamental question of whether a protein's final tertiary conformation, sometimes called the native state, can be predicted from its primary amino acid sequence is also of vital importance in understanding the protein's potential capacity to form disease-inducing aggregates. MISS A FOLD, PROMPT A DISEASE Here's a list of protein folding-related disease catego
Collage of those featured in the article
Remembering Those We Lost in 2021
Lisa Winter | Dec 23, 2021 | 5 min read
As the year draws to a close, we look back on researchers we bid farewell to, and the contributions they made to their respective fields.
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
Yale Prof Is First Woman To Win Warren Prize
The Scientist Staff | Jan 19, 1990 | 2 min read
Joan A. Steitz, professor of molecular biophysics and biochemistry at the School of Medicine at Yale University, New Haven, Conn., is the first woman ever to win the 118-year-old Warren Prize, presented every three years by Massachusetts General Hospital in Boston. Steitz, 48, will share the 1989 prize with the 1989 Nobel laureate in chemistry, Thomas R. Cech, professor of chemistry at the University of Colorado. Prize winners receive a plaque and $2,500. Steitz, an investigator with the Howar
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist | Dec 1, 2021 | 10+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Homing Technology Delivers Therapy to Cancerous Bone
Roni Dengler, PhD | Jul 19, 2021 | 5 min read
A clever approach to modifying already existing cancer therapies may be a game changer for treating metastatic breast cancer.

Run a Search

ADVERTISEMENT